nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cell-based model to study mechanisms of endothelial-dependent thrombin generation in response to inflammation and its modulation by hydroxychloroquine
|
Arachchillage, Deepa J. |
|
|
9 |
1 |
p. |
artikel |
2 |
Acquired factor V inhibitor in a case of pediatric venous thrombosis
|
Gupta, Sweta |
|
|
9 |
1 |
p. |
artikel |
3 |
Adeno-associated virus-based gene therapy for hemophilia–addressing the gaps
|
Miesbach, Wolfgang |
|
|
9 |
1 |
p. |
artikel |
4 |
A literature review of major surgery experience with emicizumab in people with hemophilia A without factor VIII inhibitors
|
Castaman, Giancarlo |
|
|
9 |
1 |
p. |
artikel |
5 |
Altered clot structure in pregnant women who will develop postpartum hemorrhage
|
de Moreuil, Claire |
|
|
9 |
1 |
p. |
artikel |
6 |
Andexanet alfa: trials just leave us with more questions
|
Buka, Richard J. |
|
|
9 |
1 |
p. |
artikel |
7 |
Anticoagulant management of cancer-associated thrombosis and thrombocytopenia: a retrospective chart review
|
Abbas, Umaima |
|
|
9 |
1 |
p. |
artikel |
8 |
Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT
|
Stevens, Hannah |
|
|
9 |
1 |
p. |
artikel |
9 |
Carbon dioxide alleviates platelet storage lesions via stimulating fatty acid metabolism and reducing platelet glucose consumption
|
Gu, Shunli |
|
|
9 |
1 |
p. |
artikel |
10 |
Challenges and considerations of genetic testing in von Willebrand disease
|
Seidizadeh, Omid |
|
|
9 |
1 |
p. |
artikel |
11 |
Changes in platelet maturity and reactivity following acute ST-segment elevation myocardial infarction
|
Pedersen, Oliver Buchhave |
|
|
9 |
1 |
p. |
artikel |
12 |
Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis
|
Mahmoud, Amir A. |
|
|
9 |
1 |
p. |
artikel |
13 |
Characterization of the procoagulant phenotype of amniotic fluid across gestation in rhesus macaques and humans
|
Yang, Chih Jen |
|
|
9 |
1 |
p. |
artikel |
14 |
Clinical management of bleeding manifestations in a family with the thrombomodulin C1611>A (p.Cys537Stop) mutation
|
Pierre-Louis, Serge |
|
|
9 |
1 |
p. |
artikel |
15 |
Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations
|
Stark, Marianne |
|
|
9 |
1 |
p. |
artikel |
16 |
Contemporary approaches to treat people with hemophilia: what’s new and what’s not?
|
Valentino, Leonard A. |
|
|
9 |
1 |
p. |
artikel |
17 |
Editorial Board
|
|
|
|
9 |
1 |
p. |
artikel |
18 |
Effect of plasma levels of factor VIII according to procoagulant phospholipids on the risk of future venous thromboembolism
|
Edvardsen, Magnus S. |
|
|
9 |
1 |
p. |
artikel |
19 |
Extending health equity to people with moderate and mild hemophilia A: revisiting the HAVEN 6 trial
|
Hermans, Cedric |
|
|
9 |
1 |
p. |
artikel |
20 |
External validation of a novel cancer-associated venous thromboembolism risk assessment score in a safety-net hospital
|
Dulberger, Karlynn N. |
|
|
9 |
1 |
p. |
artikel |
21 |
Gene therapy in hemophilia: the dawn of a new era
|
Gualtierotti, Roberta |
|
|
9 |
1 |
p. |
artikel |
22 |
Global prevalence of platelet-type von Willebrand disease
|
Seidizadeh, Omid |
|
|
9 |
1 |
p. |
artikel |
23 |
Health literacy in pediatric thrombosis: a landscape analysis
|
Bastas, Denise |
|
|
9 |
1 |
p. |
artikel |
24 |
Histologic evidence of neutrophil extracellular traps and fibrin(ogen) deposition in liver biopsies from patients with inflammatory liver disease
|
von Meijenfeldt, Fien A. |
|
|
9 |
1 |
p. |
artikel |
25 |
Immune tolerance induction for inhibitor eradication in nonsevere hemophilia A: a case series
|
Nusrat, Sanober |
|
|
9 |
1 |
p. |
artikel |
26 |
Impact of antiplatelet therapy on hemostatic plug formation in the setting of thrombocytopenia
|
Lee, Robert H. |
|
|
9 |
1 |
p. |
artikel |
27 |
Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial
|
Li, Zhengping |
|
|
9 |
1 |
p. |
artikel |
28 |
Intrinsic pathway activation in patients with antiphospholipid syndrome and healthy controls
|
van Mourik, Dagmar J.M. |
|
|
9 |
1 |
p. |
artikel |
29 |
Investigating tissue factor pathway inhibitor and other protease and protease inhibitors and their association with major adverse aortic events in patients with abdominal aortic aneurysm
|
Khan, Hamzah |
|
|
9 |
1 |
p. |
artikel |
30 |
Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?
|
Dawudi, Yachar |
|
|
9 |
1 |
p. |
artikel |
31 |
Management of patients with venous thromboembolism and a high recurrence risk estimated by the Vienna Prediction Model: a prospective cohort study
|
Šinkovec, Hana |
|
|
9 |
1 |
p. |
artikel |
32 |
Measurement of factor XIII for the diagnosis and management of deficiencies: insights from a retrospective review of 10 years of data on consecutive samples and patients
|
Al Sharif, Mohammed Abdullah |
|
|
9 |
1 |
p. |
artikel |
33 |
Mini-clusters of postadenovirus VITT
|
Lambert, Michele P. |
|
|
9 |
1 |
p. |
artikel |
34 |
No correlation between thrombin generation and emicizumab levels: implications for monitoring emicizumab therapy
|
van der Zwet, Konrad |
|
|
9 |
1 |
p. |
artikel |
35 |
Occurrence and management of thrombosis recurrence and bleeding in low-molecular-weight heparin-treated patients with cancer-associated thrombosis: a French nationwide cohort study
|
Mahé, Isabelle |
|
|
9 |
1 |
p. |
artikel |
36 |
Plasma microRNA-145-5p as a diagnostic biomarker for acute deep vein thrombosis
|
Antoun, Christopher |
|
|
9 |
1 |
p. |
artikel |
37 |
Preemptive anticoagulation during antenatal pulmonary embolism diagnostics in a community setting: retrospective cohort study
|
Campbell, Aidan R. |
|
|
9 |
1 |
p. |
artikel |
38 |
Prevalence and clinical impact of disseminated intravascular coagulation in acute aortic dissection: a nationwide cohort study
|
Murao, Shuhei |
|
|
9 |
1 |
p. |
artikel |
39 |
Prophylactic use of recombinant ADAMTS-13 during pregnancy for congenital thrombotic thrombocytopenic purpura
|
Colliou, Éloïse |
|
|
9 |
1 |
p. |
artikel |
40 |
Real-world andexanet alfa utilization and the association between delay in administration due to hospital transfer and all-cause inpatient mortality
|
Fan, Huiqiao |
|
|
9 |
1 |
p. |
artikel |
41 |
Recombinant factor VIIa: new insights into the mechanism of action through product innovation
|
Escobar, Miguel A. |
|
|
9 |
1 |
p. |
artikel |
42 |
Reduced- versus full-dose anticoagulants for the extended treatment of cancer-associated venous thromboembolism in Thai patients
|
Vichaidit, Kawin |
|
|
9 |
1 |
p. |
artikel |
43 |
Relevance of anti–platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic
|
Gendron, Nicolas |
|
|
9 |
1 |
p. |
artikel |
44 |
Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies
|
Vladic, Nikola |
|
|
9 |
1 |
p. |
artikel |
45 |
Sex-specific cut-off for dilute Russell’s viper venom time lupus anticoagulant test may be of value
|
Tang, Ning |
|
|
9 |
1 |
p. |
artikel |
46 |
Should a history of venous thromboembolism be considered a contraindication for scuba diving?
|
Vannini, Mathilde |
|
|
9 |
1 |
p. |
artikel |
47 |
Silencing of the von Willebrand factor gene in proatherothrombotic APOE∗3-Leiden.CETP transgenic mice
|
Jongejan, Yvonne K. |
|
|
9 |
1 |
p. |
artikel |
48 |
Structural bioinformatics for rational drug design
|
Mozaffari, Soroush |
|
|
9 |
1 |
p. |
artikel |
49 |
The detrimental impact of ferritin “normal” ranges on diagnosis of bleeding disorders in women
|
Sholzberg, Michelle |
|
|
9 |
1 |
p. |
artikel |
50 |
The Functional Characterization of Venous Thromboembolic Disease (FUVID) study: rationale, design, and methods of a prospective, observational, multicenter study to evaluate mechanisms of exercise intolerance and dyspnea following pediatric pulmonary embolism
|
Zia, Ayesha |
|
|
9 |
1 |
p. |
artikel |
51 |
The risk for psychiatric disorders in offspring from thrombosis-prone pedigrees in Sweden: a nationwide family study
|
Zöller, Bengt |
|
|
9 |
1 |
p. |
artikel |
52 |
Thromboprophylaxis in multiple myeloma
|
Frenzel, Laurent |
|
|
9 |
1 |
p. |
artikel |
53 |
Time trends of catheter-directed treatment in acute pulmonary embolism in Germany
|
Keller, Karsten |
|
|
9 |
1 |
p. |
artikel |
54 |
Transcription factor RUNX1 regulates coagulation factor XIII-A (F13A1): decreased platelet-megakaryocyte F13A1 expression and clot contraction in RUNX1 haplodeficiency
|
Del Carpio-Cano, Fabiola |
|
|
9 |
1 |
p. |
artikel |
55 |
Transfusion in trauma: empiric or guided therapy?
|
Barrett, Liam |
|
|
9 |
1 |
p. |
artikel |
56 |
Trenonacog alfa safety, efficacy, and pharmacokinetics in previously treated pediatric hemophilia B
|
Vilchevska, Kateryna |
|
|
9 |
1 |
p. |
artikel |
57 |
Type of D-dimer assay determines the diagnostic yield of computed tomography in patients suspected for pulmonary embolism
|
Assmann, Jorn L.J.C. |
|
|
9 |
1 |
p. |
artikel |
58 |
Validation of the 5-SNP score for the prediction of venous thromboembolism in a Danish fast-track cohort of 6789 total hip and total knee arthroplasty patients
|
Smeets, Mark J.R. |
|
|
9 |
1 |
p. |
artikel |
59 |
Venous thromboembolism still leads on maternal death
|
Shard, Amelia |
|
|
9 |
1 |
p. |
artikel |